Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Boe Technology Group Co., Ltd.

Clinical trials sponsored by Boe Technology Group Co., Ltd., explained in plain language.

Not yet recruiting 1

Immune booster: NK cells join standard care for advanced cancers

Disease control Not yet recruiting

This early-phase study tests whether adding donor natural killer (NK) cells to standard maintenance therapy can safely help control advanced solid tumors, including non-small cell lung cancer and colorectal cancer. About 20 adults aged 18-75 will receive NK cell infusions alongsi…

Phase: PHASE1, PHASE2 • Sponsor: BOE Technology Group Co., Ltd. • Aim: Disease control

Last updated May 22, 2026 14:03 UTC